Hannigan Todd buys $1.1M of IPX

The Transaction

Hannigan Todd, Executive Chairman and director of IperionX Limited (IPX), purchased 260,000 open-market shares of IPX for $1,091,766 at an average price of $4.1991 on 2026-04-29, per a same-day filed Form 4 with the SEC. Todd completed a second open-market purchase later that same day, acquiring 220,000 additional shares at $4.4819 for $986,018, bringing his total capital deployed on 2026-04-29 to $2,077,784 for 480,000 total IPX shares. IPX has a current reported market capitalization of $1.1 billion.

Insider Context

Todd’s April 29 purchases represent the largest open-market insider transactions at IPX in the 90-day window leading up to the filing. Over that period, only one other executive has made an uncompensated open-market share buy: Chief Executive Officer Anastasios Arima purchased 110,000 shares on 2026-04-30 for $493,625 at $4.4875 per share. All other recent insider activity documented via Form 4 consists of zero-cost equity awards, including 52,258 shares awarded to CFO Marcela Rocha on both 2026-04-02 and 2026-04-30, and multi-million dollar stock awards to President Toby Edgcumbe in early April 2026 with no personal capital required. No Form 4 filings showing insider selling at IPX appear in the provided recent transaction data.

Cross-Reference to Institutional and Analyst Activity

IPX’s analyst rating landscape has been uniformly bullish since February 2026, with 5 Buy ratings assigned as of 2026-04-01, up from 4 Buy ratings in January 2026. For institutional holdings, the latest available 13F data as of 2025-12-31 shows 47 total institutional holders, a net increase of 7 positions from the prior period, with 34 firms increasing their holdings and 17 establishing new positions. Total institutional ownership equals 10.9% of IPX’s float, with aggregate holdings valued at $0.1 billion. The April 29, 2026, transaction coincided with a public company investor update announcing scaled-up U.S. titanium production, per SEC filings and associated news coverage.

What This Transaction Does NOT Signal

First, this open-market buy does not signal a near-term earnings surprise: the most recent reported quarterly results from IPX, released 2026-03-12, showed an EPS miss of $0.06 relative to consensus estimates of -$0.04. Second, the purchase does not reflect unanimous executive sentiment: while Todd and Arima deployed personal capital, other insiders received fully diluted equity awards with no out-of-pocket cost. Third, the transaction does not indicate an imminent shift in institutional holding levels, as the latest 13F filing predates the purchase by four full months.